Limba
Romanian
Romanian
English|
Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262), 1mg*25
32.845,19 RON
SKU
SKM_A2758_1mg*25
Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD.
| Price | 27.601,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD. |
